BrainVectis ropes in $1.1 mln
Paris-based BrainVectis, which is focused on treating Alzheimer's and Huntington diseases, has raised $1.1 million. The investors were not named.
13 September 2016•1 min read
Paris-based BrainVectis, which is focused on treating Alzheimer's and Huntington diseases, has raised $1.1 million. The investors were not named.
